Home > Healthcare > Medical Devices > Diagnostic Devices > Corneal Topographers Market
The corneal topographers market by product type is categorized into placido disc system, scheimpflug systems, and scanning slit system. The placido disc system segment garnered USD 309 million revenue size in the year 2022. Placido disc system are one of the initially developed technologies for corneal topographers that improves corneal disease monitoring and helps in early diagnosis as compared to alternate screening techniques. The systems are used in many different applications to aid medical professionals in understanding corneal morphology. These play a significant role in the diagnosis of disorders such as pellucid marginal dystrophy, orthokeratology, keratoconus, contact lens practice, refractive surgery patient management, post keratoplasty, and intraocular lens (IOL) calculation among others.
Based on application, the corneal topographers market is segmented into cataract surgery evaluation, corneal disorder diagnosis, refractive surgery evaluation, contact lens fitting, and others. The refractive surgery evaluation segment dominated accounted for over 31% market share in the year 2022. The dominance of the refractive surgery evaluation segment in the industry is majorly owing to its critical role in precise pre-operative assessments for refractive surgical procedures. Moreover, advancements in technology enhancing assessment accuracy and the rising popularity of refractive surgeries, especially among younger demographics, further contribute to the segment's significance.
Based on end-use, the corneal topographers market is segmented into hospitals, ambulatory surgery centers, ophthalmic clinics, and others. The hospitals segment accounted for over 39% market share in the year 2022. Hospitals offers wide range of eye care services, including surgery, treatment, and diagnosis for several eye conditions. Corneal topography can be used to assess these eye conditions, including corneal dystrophies, keratoconus, and anomalies in the cornea as hospitals continue investing in advanced diagnostics, the adoption of corneal topography devices is anticipated to rise, fuelling market expansion.
U.S. corneal topographers market accounted for USD 259 million revenue size in 2022 due to the rising prevalence of age-associated ophthalmic conditions. For instance, as per the Centers for Disease Control and Prevention (CDC), over 30 million adults aged 40 and above are impacted by age-related eye ailments in the U.S. Moreover, the country's advanced healthcare infrastructure, access to cutting-edge medical technologies, and strong research and development focus have contributed to its leadership. Additionally, presence of key market players, government initiatives, and favourable policies have collectively propelled the adoption of corneal topography procedures in the U.S.